1 mL BAC
10 units
resulting U-100 draw
- Concentration
- 20 mg/mL
- BAC added
- 1 mL
SingleInvestigationalMixedVery Low confidenceSourced
Pinealon
A short peptide bioregulator studied mainly in laboratory, ageing and limited regional clinical literature. Evidence quality and formulation mapping are weak.
Evidence context, not a personal protocol
Quantities below reproduce their stated source context—label, human study, laboratory work or educational guide. They do not assess suitability, product equivalence or individual risk.
Community-reported schedule
Community-reported · not a validated scheduleCommunity dose schedule
Two community-provenance subcutaneous lines from an authenticated research forum - a heavier ~2 mg/day 20-day cycle and a low-and-slow 100 to 500 mcg before-bed sleep pattern. Community reports only, not a validated schedule.
Reported maximum quantityChoose the maximum quantity reported by this community line. Any earlier phase can be selected below for its arithmetic.
Reported cycle phases
Select a point for its calculation examples- Daily cycle (~20 days)2 mgHeavier anti-ageing pattern; the reported range spans 100 mcg to 6 mg per day and quantities conflict widely.
Vial-aware arithmetic
Reconstitution examples, up to 3 mL
Choose the vial quantity and BAC water first. The diagram and results below update for the selected 2 mg reported quantity. Higher-strength vials may naturally land outside the 20-30 unit band.
BAC water selected
2 mL
Basic example limit: 3 mL maximum. Check the actual vial and product-specific limits.
U-100 draw20 U
20-30 U reference band
2 mL BAC
20 units
resulting U-100 draw
- Concentration
- 10 mg/mL
- BAC added
- 2 mL
Shown in the diagram. Closest of these examples to 25 units.
3 mL BAC
30 units
resulting U-100 draw
- Concentration
- 6.667 mg/mL
- BAC added
- 3 mL
Formula: draw units = selected mg × BAC mL ÷ vial mg × 100. The 20-30 unit band is a measurement reference, not a recommendation. Results are mathematical examples, not preparation instructions.
Dosage and protocol evidence
Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.
Community GuideSubcutaneous in guideDaily
Third-party educational bioregulator schedule
1 mg daily on days 1-5, 1.5 mg on days 6-14 and 2 mg on days 15-20
The source presents a 10-20 day community cycle. Sparse regional literature does not establish this as a replicated or product-equivalent human regimen.
View sourceCommunity GuideOral, subcutaneous or intramuscular in reportsDaily or twice daily during short cycles
online research community bioregulator channel
The spotlight states 20-40 mg orally daily for 10-20 days or 100-200 mcg subcutaneously or intramuscularly twice daily for 10-20 days
Community courses instead range from roughly 200 mcg to 2 mg daily, with still higher purported book schedules. The archive does not resolve this order-of-magnitude disagreement; raw/bioregulators/bio-pinealon.md:26-28 and 204-340.
View sourceCommunity GuideSubcutaneous, oral or intranasal in reportsNightly or daily during short cycles
authenticated research-forum (Peppys) reports and a sleep-stack protocol
Subcutaneous sleep reports run low-and-slow, roughly 100-500 mcg before bed, often inside an Epithalon and DSIP stack; a heavier anti-ageing pattern uses about 2 mg daily for a 10-20 day cycle repeated 2-3 times a year. The full reported spread is 100 mcg to 6 mg per day, with oral (about 100-200 mcg) and intranasal (about 0.2 mg) figures quoted separately
Forum provenance with usernames omitted. Quantities conflict by orders of magnitude, partly from mcg and mg mix-ups, and routes are not interconverted. Effects are described as gradual and sometimes stimulating rather than sedating, and injection sting is managed with sodium bicarbonate.
View sourceEvidence summary
A short peptide bioregulator studied mainly in laboratory, ageing and limited regional clinical literature. Evidence quality and formulation mapping are weak.
Protocol basis
Because the indexed literature is sparse and heterogeneous, the protocol page focuses on evidence provenance rather than retail schedules.
Community provenance (Peppys)
An authenticated research-forum archive shows a consistent split aimed at sleep and cognition: a low-and-slow pattern of roughly 100-500 mcg subcutaneously before bed, versus a heavier anti-ageing pattern near 2 mg per day for a 10-20 day cycle. Reported quantities conflict widely, spanning 100 mcg to 6 mg per day, partly because members mix up mcg and mg and because oral and intranasal figures get conflated; the archive keeps these routes separate. Pinealon most often appears inside an Epithalon and DSIP sleep stack, effects are described as gradual and sometimes stimulating, and injection sting is managed with sodium bicarbonate. Usernames are omitted and the figures are community provenance; the planner above reproduces their arithmetic without validating them.
What remains uncertain
Independent replication, route-specific pharmacokinetics, clinically meaningful outcomes and long-term safety remain uncertain.
Warnings and contraindications
Internationally accessible controlled human evidence is limited.
Oral, intranasal and injectable claims cannot be treated as interchangeable.
Neurological and ageing claims remain insufficiently validated.
Shared across protocols
Supplies and general handling
Keep the universal checklist short. Product-specific labelling and source documentation always take priority over a general guide.
Research vial
Select the labelled vial quantity used in the calculation.
View Peppys vialBacteriostatic water
Use only a diluent appropriate to the research method and formulation.
View Peppys BAC waterU-100 measuring syringe
Use a new sterile device for every entry. Source locally.
Source locallyWipes and sharps container
Plan clean handling and immediate sharps disposal. Source locally.
Source locallyStorage follows the label
Do not apply a universal refrigerator rule. Follow the product, diluent and study documentation for temperature, light and expiry.
Use sterile equipment once
CDC injection-safety guidance calls for a new sterile needle and syringe for each injection and entry into a medication container.
Stability is formulation-specific
Do not infer a post-mixing lifetime from BAC water alone. Discard material when identity, integrity or sterility is in doubt.